Drug Discovery Institute

The Drug Discovery Institute explores new approaches to the discovery of novel therapeutics, in addition to supporting more traditional approaches. The primary strategy is to combine expertise in computation and systems biology at Pitt and Carnegie Mellon University with crucial patient samples from UPMC. The Institute is at the forefront of the emerging field of quantitative systems pharmacology.  Learn more.